Eloise McLennan

There is no denying that artificial intelligence (AI) has captured the imagination of innovators working across the pharmaceutical sector. The drug discovery space is no different, with myriad applications promising to revolutionise the way that researchers and sponsors approach identifying and progressing new drug candidates.

Stay updated on the latest trends and developments in the pharmaceutical industry with Reuters Pharma Europe 2024. Get insights, analysis, and news related to pharmaceuticals in Europe.

Get insights and highlights from Day One of Reuters Pharma Europe 2024, focusing on the latest in technology and pharmaceutical advancements. Stay updated on key developments in the industry.

Gain insights into market access strategies for 2024 with a deep dive featuring perspectives from industry leaders such as Alexion, Putnam, Inizio Advisory, and insights from Reuters Pharma US.

An insightful interview with Peter Stenico, global head of biosimilars and country president, Sandoz Austria at Reuters Pharma Europe, Barcelona 2024

Value-based healthcare has long been the holy grail for payers and patients. But the timeline for achieving it grows shorter. Will they find it before it’s too late?

Deep Dive: AI 2024

Market Access and Commercialisation 2025

From the White House to AI drug discovery: Dr Rahul Gupta on tackling America’s opioid crisis

Equity and Sustainability 2025